Announce Date | 05/14/2025 |
EPS Normalized Actual | $-0.52 (Beat by $0.17) |
EPS GAAP Actual | $-0.52 (Beat by $0.17) |
Revenue Actual | $0.005322B |
Revenue Surprise | Beat by $5.322M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.96 |
EPS GAAP Estimate | $-0.96 |
Revenue Estimate | $0.021755B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | -0.65 | -2.38 | -0.69126 | -0.617 | 0 |
Dec 2025 | -0.38 | -4.08 | -0.38 | -0.38 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2017 (Mar 2017) | -2.79 | -2.79 | 0.005322B | 100% | 5.32M |
FQ2 2017 (Jun 2017) | -2.71 | -2.71 | 0.005631B | 100% | 5.63M |
FQ3 2017 (Sep 2017) | -4.55 | -4.55 | 0.012392B | 100% | 12.39M |
FQ4 2017 (Dec 2017) | -5.26 | -5.26 | 0.013114B | 100% | 13.11M |
FQ1 2025 (Mar 2025) | -0.52 | -0.44 | 0.01536B | -31.6% | -4.83M |
FQ4 2024 (Dec 2024) | -0.18 | 0.42 | 0.024607B | -33.11% | -1.36M |
FQ3 2024 (Sep 2024) | -0.25 | 0.75 | 0.026239B | -51.18% | 4.58M |
FQ2 2024 (Jun 2024) | -0.52 | -1.85835 | 0.027984B | -26.01% | -42.54M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.96
Consensus Revenue Estimates
0.021755B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | -0.38 | -- | -0.38802 | -0.36947 | 1 |
FQ3 2026 (Sep 2026) | -0.3 | -- | -0.30633 | -0.29168 | 1 |
FQ2 2026 (Jun 2026) | -0.26 | -- | -0.26548 | -0.25279 | 1 |
FQ1 2026 (Mar 2026) | -0.64 | 18.75 | -0.6535 | -0.62226 | 1 |
FQ4 2025 (Oct 2025) | -0.6 | 70 | -0.62812 | -0.5798 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.03B | -- | 0.03B | 0.03B | 1 |
FQ3 2026 (Sep 2026) | 0.03B | -- | 0.03B | 0.03B | 1 |
FQ2 2026 (Jun 2026) | 0.03B | -- | 0.03B | 0.03B | 1 |
FQ1 2026 (Mar 2026) | 0.02B | 27.13 | 0.02B | 0.02B | 1 |
FQ4 2025 (Oct 2025) | 0.03B | 10.11 | 0.03B | 0.03B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2017 (Mar 2017) | -2.79 | -2.79 | 100% | |
FQ2 2017 (Jun 2017) | -2.71 | -2.71 | 100% | |
FQ3 2017 (Sep 2017) | -4.55 | -4.55 | 100% | |
FQ4 2017 (Dec 2017) | -5.26 | -5.26 | 100% | |
FQ1 2025 (Mar 2025) | -0.08 | -0.52 | -0.44 | 84.62% |
FQ4 2024 (Dec 2024) | -0.6 | -0.18 | 0.42 | -233.33% |
FQ3 2024 (Sep 2024) | -1 | -0.25 | 0.75 | -300% |
FQ2 2024 (Jun 2024) | 1.33835 | -0.52 | -1.85835 | 357.38% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2017 (Mar 2017) | $0B | $0.01B | $5.32M | 100% |
FQ2 2017 (Jun 2017) | $0B | $0.01B | $5.63M | 100% |
FQ3 2017 (Sep 2017) | $0B | $0.01B | $12.39M | 100% |
FQ4 2017 (Dec 2017) | $0B | $0.01B | $13.11M | 100% |
FQ1 2025 (Mar 2025) | $0.02B | $0.02B | $-4.83M | -31.47% |
FQ4 2024 (Dec 2024) | $0.03B | $0.02B | $-1.36M | -5.53% |
FQ3 2024 (Sep 2024) | $0.02B | $0.03B | $4.58M | 17.44% |
FQ2 2024 (Jun 2024) | $0.07B | $0.03B | $-42.54M | -152.03% |